marijuana stock news

Cara Therapeutics to Present at the Virtual 19th Annual Needham Healthcare Conference

A live webcast of the presentation can be accessed under “Events & Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days.

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral KORs. Cara is developing a novel and proprietary class of product candidates, led by KORSUVA (CR845/difelikefalin), a first-in-class KOR agonist that targets KORs located in the peripheral nervous system and on immune cells. In the Company’s KALM-1 Phase 3 trial and two Phase 2 trials, KORSUVA (CR845/difelikefalin) Injection has demonstrated statistically significant reductions in itch intensity and concomitant improvement in pruritus-related quality of life measures in hemodialysis patients with moderate-to-severe CKD-aP and is currently being investigated in Phase 3 trials in hemodialysis patients with CKD-aP. Oral KORSUVA is in Phase 2 trials for the treatment of pruritus in patients with CKD, AD and PBC.

The FDA has conditionally accepted KORSUVA as the trade name for difelikefalin injection. CR845/difelikefalin is an investigational drug product and its safety and efficacy have not been fully evaluated by any regulatory authority.

INVESTOR CONTACT:
Jane Urheim
Stern Investor Relations, Inc.
212-362-1200
jane.urheim@SternIR.com

MEDIA CONTACT:
Annie Starr
6 Degrees
973-415-8838
astarr@6degreespr.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Emblem Corp. (EMMBF) launches Atmosphere, its first oral dose-metered spray

Emblem launches Atmosphere, its first oral dose-metered spray Emblem Corp. (TSXV: EMC,…

GTEC Holdings Ltd. (GTEC.V) (GGTTF) Enters into Agreement to Acquire Facility in Kelowna BC

GTEC Enters into Agreement to Acquire Facility in Kelowna BC GTEC Holdings…

The Supreme Cannabis Company, Inc. (SPRWF) (FIRE) Second Quarter Earnings Release Scheduled for February

Supreme Cannabis Second Quarter Earnings Release Scheduled for February 13, 2020  …

HEXO MED, an affiliate of HEXO Corp (HEXO) secures medical cannabis license in Europe

HEXO MED, an affiliate of HEXO Corp, secures medical cannabis license in…